Immediate Impact
10 from Science/Nature 87 standout
Citing Papers
Colorectal cancer
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Works of M. Rother being referenced
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
2010 Standout
Randomized phase III study of panitumumab (pmab) with FOLFOX4 compared to FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): PRIME trial analysis by epidermal growth factor receptor (EGFR) tumor staining.
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Rother | 1259 | 565 | 355 | 363 | 8 | 1.4k | |
| Allert H. Vos | 1325 | 532 | 324 | 312 | 11 | 1.6k | |
| Yousif Abubakr | 1068 | 480 | 179 | 330 | 7 | 1.2k | |
| Yevhen Hotko | 1197 | 592 | 307 | 276 | 26 | 1.4k | |
| M. Elisa Vink-Börger | 1266 | 524 | 484 | 351 | 9 | 1.6k | |
| Joseph J. Schulz | 1279 | 523 | 146 | 460 | 8 | 1.5k | |
| Joe McKendrick | 845 | 407 | 171 | 288 | 9 | 1.1k | |
| Belguendouz Bendahmane | 1053 | 417 | 259 | 290 | 16 | 1.2k | |
| M. E. Vega-Villegas | 931 | 542 | 177 | 224 | 17 | 1.2k | |
| Claus-Christoph Steffens | 946 | 467 | 161 | 303 | 18 | 1.1k | |
| Alan Rong | 825 | 366 | 262 | 233 | 26 | 1.0k |
All Works
Loading papers...